Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system - ScienceDirect
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in NADPH Oxidase 1 (Nox1), C‐C Chemokine Receptor Type 5 (CCR5), and Inflammation | Journal
Frontiers | Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives
Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective
Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation
Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 - ScienceDirect
Therapeutic advances in COVID-19 | Nature Reviews Nephrology
Frontiers | Modalities and Mechanisms of Treatment for Coronavirus Disease 2019
Life | Free Full-Text | Statins in COVID-19 Therapy
Epidemic and pandemic viral infections: impact on tuberculosis and the lung | European Respiratory Society
Research Highlight: Derivatization and Combination Therapy of COVID-19 Therapeutic agents | LAU News
Paxlovid- history and mechanism of action - Santiago lab
A global treatments for coronaviruses including COVID‐19 - Yousefi - 2020 - Journal of Cellular Physiology - Wiley Online Library
Emerging pharmacotherapies for COVID-19 - ScienceDirect
Emerging pharmacotherapies for COVID-19 - ScienceDirect
Structural biology of SARS-CoV-2: open the door for novel therapies | Signal Transduction and Targeted Therapy
Oral antiviral treatments for COVID-19: opportunities and challenges | SpringerLink
Review of pharmacologic and immunologic agents in the management of COVID-19 | Biosafety and Health
Biomolecules | Free Full-Text | SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
Remdesivir and its antiviral activity against COVID-19: A systematic review - Clinical Epidemiology and Global Health
Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials | Bentham Science
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
Paxlovid: Mechanism of Action, Synthesis, and In Silico Study
Infectious diseases | Nature Reviews Drug Discovery
How Ritonavir acts as booster drug - YouTube
